(HealthDay)—About 14.5 million U.S. cancer survivors are alive today, compared to just 3 million in 1971, the American Association for Cancer Research reported Tuesday.
16 hours ago
5 / 5 (1) | 1
Two mutations that cause lung cancer resistance to the investigational ALK inhibitor alectinib were identified, and this information may help design new treatment regimens for patients with ALK-positive lung cancer, according ...
14 hours ago
5 / 5 (1) | 0